Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma (Q33378734)
scientific article
Language:
Current Data About Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma
(P31) (Q13442814)
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P50) (Q88248387)
(P1545) 9
(P1932) B D Cheson
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P304) 964-969
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P433) 5
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P478) 19
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P577) Thursday, February 21, 2008
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P921) (Q42824440)

(Q208414)

(P1433) (Q326122)
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P1476) "Phase II trial of oral vorinostat (suberoylanilide hydroxamic acid) in relapsed diffuse large-B-cell lymphoma" (language: en)
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

(P2093) M Crump
(P1545) 1
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

B Coiffier
(P1545) 2
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

E D Jacobsen
(P1545) 3
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

L Sun
(P1545) 4
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

J L Ricker
(P1545) 5
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

H Xie
(P1545) 6
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

S R Frankel
(P1545) 7
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

S S Randolph
(P1545) 8
(P248)
(P698) 18296419
(P813) Wednesday, July 26, 2017

other details
description scientific article

External Links
(P356) 10.1093/ANNONC/MDN031
(P698) 18296419
(P5875) 5556644